VRTX · NASDAQ · Biotechnology

Vertex Pharmaceuticals (VRTX)

Develops cystic fibrosis medicines, gene-edited cell therapy, and non-opioid pain treatment.

$520.44
vs last close+9.72 (+1.90%)
  1. Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report?

    Zacks Investment ResearchMarket move